COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 112: Articles 1111-1120  | Next

Safety and Immunogenicity of Fractional Doses of COVID-19 Vaccines among Nigerian Adults- A Randomised Non-Inferiority trial
Salako, A., Musa, A., Ige, F. A., Abdullahi, A., Ayorinde, J., Ekama, S., Odubela, O., Idigbe, I., Ajibaye, S., Mazharul, A., Adeneye, K., Akinsolu, F., Olojo, I., Okwuraiwe, A. P., Egherbva, H., Ekpeyong, M., Elemuwa, U., Ezenyi, I., Bitrus, F., Odubela, O., Oba, A., Idris, G., Jimoh, Y., Garba, A., Yahya, B., Babamaiyaki, M., Ezejiofor, O., Ejiro, B., Rosenzweig, L., Adigwe, O. P., Adeyeye, M., Shuaib, F., Wiecek, W., Hamada, Y., Ezechi, O., Gupta, R. K., Salako, B.
10.1101/2024.11.21.24317533 — Posted: 2024-11-22
Rapid establishment of public sector COVID-19 test and treatment programs across seven low- and middle-income countries: Implementation strategies and program monitoring results
Boeke, C. E., Hamza, N., Agwuocha, C., Amako, O., Detluexay, K., Gao, M., Griffith, B. C., Gumulira, Y., Hodges, E. U., Joseph, J., Lufesi, N., Macharia, E., Mbewe, N., McCarthy, E., Mintah, F. O., Mukiibi, M., Mulenga, M., Ngwije, A., Ofori-Boadu, L., Okoli, I. U., Phongphila, S., Ramers, C., Regan, S., Twinomujuni, E., Rwagasore, E., Tebor, J., Udayakumar, K.
10.1101/2024.11.21.24317710 — Posted: 2024-11-22
Recovery and long-term health outcomes of SARS-CoV-2 infection in a prospective cohort in an urban setting, Kenya
Kisiangani, I., Ben, A. J., Wynberg, E., Wami, W., Iddi, S., Kinya, I., Vasall, A., Kyobutungi, C., Ziraba, A., Njeru, J., Mugenda, O., Kiguoya, M., de Jong, M. D., Mohamed, S. F., Asiki, G., Schultsz, C.
10.1101/2024.11.21.24316116 — Posted: 2024-11-22
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2
Esmaeili-Wellman, S. S., Owens, K., Wagoner, J., Polyak, S. J., Zhang, S., Standing, J. F., Lowe, D. M., Schiffer, J.
10.1101/2024.11.21.24317726 — Posted: 2024-11-22
In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants
Bendall, E. E., Dimcheff, D., Papalambros, L., Fitzsimmons, W. J., Zhu, Y., Schmitz, J. E., Halasa, N., Chappell, J. D., Martin, E. T., Biddle, J. E., Smith-Jeffcoat, S. E., Rolfes, M. A., Mellis, A., Talbot, H. K., Grijalva, C. G., Lauring, A. S.
10.1101/2024.11.21.624722 — Posted: 2024-11-22
The nucleocapsid (N) proteins of different human coronaviruses demonstrate a variable capacity to induce the formation of cytoplasmic condensates
Tikhomirova, M. A., Kuzmenko, O. L., Arifulin, E. A., Shirokova, O. M., Musinova, Y. R., Sheval, E. V.
10.1101/2024.11.20.624003 — Posted: 2024-11-21
From protection of sacrificial self to critical turning points and growth: Nurses experiences on the frontline during the COVID-19 pandemic.
Creedon, S., Trace, A.
10.1101/2024.11.19.24317599 — Posted: 2024-11-20
The impact of vaccination on preventing long COVID in the Omicron era: a systematic review and meta-analysis
Green, R., Marjenberg, Z., Lip, G. Y. H., Banerjee, A., Wisnivesky, J., Delaney, B. C., Peluso, M. J., Wynberg, E., Abduljawad, S.
10.1101/2024.11.19.24317487 — Posted: 2024-11-20
The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South Korea
Sharbayta, S. S., Jo, Y., Jung, J., Buonomo, B.
10.1101/2024.11.19.24317549 — Posted: 2024-11-20
Excess weight increases the risk for neurological and neuropsychiatric symptoms in post-COVID-19 condition: A systematic review and meta-analysis
Ronca, D. B., Mesquita, L. O., Oliveira, D. b., Figueiredo, A. C. M. G., Wen, J., Song, M., de Carvalho, K. M. B.
10.1101/2024.11.20.24317635 — Posted: 2024-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).